Gofore just announced it is joining forces with an AI-focused niche company, founded by key employee...
Redeye briefly comments on Truecaller releasing an update regarding its Q4 2025 revenue development,...
We expect Q4 to show continued positive momentum, supported by recent trends in key franchises and a...
On 11 December 2025, Hella announced its first series production order for High-Resolution Radar (HR...
The announcement of Nanexa’s first licensing deal marks a meaningful validation of the PharmaShell p...
Smart Eye has successfully issued a SEK300m senior unsecured bond at 3M STIBOR + 7%, which we view a...
Due to longer sales cycles in the UK and Germany, Careium announced its full-year 2025 guidance will...
Vi inleder bevakning på Online Brands Nordic, en snabbväxande e-handelskoncern som förvärvar, äger o...
Inderes delivered solid monthly sales in November with sales increasing by 15% y/y.
I väntans tider med rekordkvartal i ryggen för Railcare: Nya uppdrag bör rulla in under vintern för ...
Redeye resumes coverage and updates its view on Gapwaves following the Q3 report and the completion ...
Kalqyl och Fairvalue lanserar nu NGM Company Insights, en samlad genomgång av nio tillväxtbolag note...
Systemair levererar sitt starkaste kvartal hittills med högre försäljning än väntat, stigande margin...
* Mark Waugh appointed new CEO * Relevant background from orthapaedic industry * Supportive for sent...
Gofore's November sales lagged slightly behind our estimate, as in October.
Redeye comments on the recently announced TetraGraph order from one of the leading NHS hospital trus...
Redeye updates its estimates and valuation after Surgical Science’s capital markets day.
* Ny levereans till Chr. Olesen inom ramen för avropsordern * Ordern motsvarar cirka 2,6 MSEK * Kort...
Redeye comments on today's announcement that Acarix has carried out a directed share issue of approx...
Redeye leaves a comment following Cinclus’ announcement that its lead candidate, linaprazan glurate,...
